The Billion Dollar Blindspot

The Billion Dollar Blindspot

Home
Capital Briefing
Women's Health Investing
Intelligence
Healthcare AI
About

Why Great Healthcare Ideas Still Fail

LATEST
·
26:15
Women's health is a mispriced market. This is where serious investors track it.

Women's Health Investing

View all
When Women's Health Meets Institutional Capital
Why venture capital growth alone may not be enough for women's health to become an institutional investment category.
 • Maryann Selfe
Why Women's Health Is the First Test of Precision Health
How biological time is reshaping medicine, innovation and healthcare investing.
 • Maryann Selfe
The Women’s Health Capital Thesis: Why Precision Health Is Becoming an Institutional Investment Opportunity
How sex-specific medicine, emerging healthcare LP demand, the Great Wealth Transfer, and specialist-manager access are reshaping women’s health…
 • Maryann Selfe
The System That Ate Healthcare
How aging populations, rising costs, and institutional inertia quietly reshaped medicine into one of the largest sectors of the modern economy.
 • Maryann Selfe
The Signals I’m Watching in Women’s Health as 2026 Approaches
An investor’s view on where distribution power, evidence, and risk are quietly shifting
 • Maryann Selfe
When Care Becomes Capital: Inside the $18 Billion Women’s Health Deal Reshaping Medicine
Blackstone and TPG’s acquisition of Hologic isn’t just a medtech move. It’s a cultural signal. Here’s what it reveals about the next trillion-dollar…
 • Maryann Selfe
📌 Helpful Resources
FemmeHealth Alliance
strengthen collaboration and visibility for women’s health innovation
The Billion Dollar Blindspot
Why Women's Health is the Investment Opportunity of our Time

Women's Health

View all
What Novo Nordisk’s Failed Heart-Drug Trial Really Tells Investors
What ZEUS means for Novo’s pipeline and how far investors should apply its result.
 • Maryann Selfe
The People Building the Future of Women’s Health
The Billion Dollar Blindspot is opening its pages to founders, investors, clinicians, researchers and industry leaders with valuable perspectives to…
 • Maryann Selfe
The Questions Nobody Funded: ADHD in Women and the Hidden Economics of Medical Research
What one rejected study reveals about research funding, hormones, perimenopause and why some of medicine's most important questions remain unanswered.
 • Maryann Selfe
When Care Becomes Leverage: Who Owns Women’s Health Infrastructure?
Women’s health needs more capital. But as clinics consolidate, the more urgent question is whether ownership models protect continuity of care, clinical…
 • Maryann Selfe
Being Diagnosed Isn't the Same as Being Studied
The ADHD treatments women are now receiving were built before anyone thought to ask how female biology affects the way they work. That oversight has a…
 • Maryann Selfe
Was ADHD Built for Boys? Why Thousands of Women Are Being Diagnosed Decades Later
For decades, ADHD was understood through the boys who couldn't sit still. But as growing numbers of women receive diagnoses in midlife, a deeper…
 • Maryann Selfe
Recommendations
View all 20
The Feminist Lens
The Feminist Lens
The Feminist Lens
The VC Corner
The VC Corner
Ruben Dominguez
Marketing Ideas
Marketing Ideas
Tom Orbach
Own Your Ambition
Own Your Ambition
Bonnie Marcus
AI Health Uncut
AI Health Uncut
Sergei Polevikov
👉 Weekly updates delivered straight to your inbox
👉 Weekly updates delivered straight to your inbox

Subscribe

Institutional investment intelligence on women’s health, Healthcare AI and the capital shaping the future of healthcare.
AboutArchiveRecommendationsSitemap

The Billion Dollar Blindspot

© 2026 Maryann Selfe · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture